- Home
- ESPR vs USCB Comparison
ESPR vs USCB Comparison
Compare ESPR & USCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- USCB
- Stock Information
- Founded
- ESPR 2008
- USCB 2002
- Country
- ESPR United States
- USCB United States
- Employees
- ESPR N/A
- USCB N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- USCB Major Banks
- Sector
- ESPR Health Care
- USCB Finance
- Exchange
- ESPR Nasdaq
- USCB Nasdaq
- Market Cap
- ESPR 410.2M
- USCB 353.0M
- IPO Year
- ESPR 2013
- USCB 2021
- Fundamental
- Price
- ESPR $1.89
- USCB $19.75
- Analyst Decision
- ESPR Buy
- USCB Buy
- Analyst Count
- ESPR 6
- USCB 4
- Target Price
- ESPR $7.25
- USCB $16.13
- AVG Volume (30 Days)
- ESPR 5.1M
- USCB 24.8K
- Earning Date
- ESPR 02-25-2025
- USCB 01-23-2025
- Dividend Yield
- ESPR N/A
- USCB 1.28%
- EPS Growth
- ESPR N/A
- USCB 47.62
- EPS
- ESPR N/A
- USCB 1.24
- Revenue
- ESPR $295,451,000.00
- USCB $79,519,000.00
- Revenue This Year
- ESPR $186.04
- USCB N/A
- Revenue Next Year
- ESPR $11.25
- USCB $8.71
- P/E Ratio
- ESPR N/A
- USCB $15.71
- Revenue Growth
- ESPR 187.12
- USCB 25.02
- 52 Week Low
- ESPR $1.58
- USCB $10.25
- 52 Week High
- ESPR $3.94
- USCB $21.86
- Technical
- Relative Strength Index (RSI)
- ESPR 39.38
- USCB 63.16
- Support Level
- ESPR $1.71
- USCB $18.51
- Resistance Level
- ESPR $2.26
- USCB $19.97
- Average True Range (ATR)
- ESPR 0.14
- USCB 0.66
- MACD
- ESPR -0.01
- USCB 0.15
- Stochastic Oscillator
- ESPR 33.33
- USCB 77.37
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About USCB USCB Financial Holdings Inc.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.